none

IMPLANTABLE BIONIC EYE PRESENTS CURE FOR BLINDNESS

28-01-2016
by 
in 

Researchers at the University of New South Wales (UNSW) are set to begin trials of the Phoenix99, a new bionic eye that's expected to give patients vision several times better than current vision restoration technologies.

The device, which has been successfully demonstrated in pre-clinical work by a team of elite surgical experts around Sydney, recently received a funding boost to help the scientists move toward the next stage of research: human implantation.

"We were really excited by the first trial because it proved the technology and implementation technique works," said one of the inventors of the system, Gregg Suaning. "Patients 'learn' to use the technology, in the same way a person implanted with a cochlear ear implant 'learns' to hear electrical impulses."

The team at UNSW has been researching bionic eye technology since 1997, with the goal of restoring sight to people with retinitis pigmentosa – the leading cause of blindness in younger people – and age-related macular degeneration.

Retinitis pigmentosa is a degenerative condition that affects up to 2 million people globally. The condition, which often presents in patients in their 30s, can lead to complete blindness in 10 years. While medications can slow its progress, they are expensive and only available in developed countries, and scientists still don't know how to reverse the degeneration.

Bionic vision, however, is becoming an increasingly viable alternative, and in 2012 the UNSW engineers were part of a team that trialled an earlier, partially implanted prototype device with three patients with retinitis pigmentosa.

The prototype consisted of a 24-electrode array with external electronics that allowed the patients users to see spots of light, called phosphenes. With the help of special cameras, the users could also get a sense of distance, with the phosphenes appearing brighter when still objects were closer.

Suaning and fellow co-inventor Nigel Lovell plan to implant the Phoenix99 in up to a dozen patients over the next two years.

 

Related news & editorials

  1. 21.09.2018
    21.09.2018
    by      In
    Available now from Treotham Automation, iglidur RW370 is a novel polymer material that is qualified to the EN 45545 fire protection standard for use in railway applications. The high-performance igus plastic is available as lubricant- and maintenance-free plain bearings and also as a bar stock for... Read More
  2. 21.09.2018
    21.09.2018
    by      In
    Big Ass Fans reckons that its Haiku range offers the ultimate airflow solution paired with iconic design.
    The fans are designed and manufactured to provide silent, cooling comfort to both indoor and outdoor spaces. With a world reputation for excellence, Haiku uses ultra-efficient DC motors and... Read More
  3. 20.09.2018
    20.09.2018
    by      In
    In stock now at RS Components, the Harting PushPull V4 series of connectors are suitable for a wide range of industrial signal data and power applications.
    The modular range of connectors is ideal for flexible manufacturing operations where processes are converted or even relocated as the PushPull... Read More
  4. 20.09.2018
    20.09.2018
    by      In
    Responding to trends in both the power generation sector and in the industrial landscape, Lapp has developed its first power cable designed specifically to carry direct current.
    Although in principle today's AC power cables can be used for carrying direct current, research has shown that direct... Read More